Last 12 months
Inside the activity.
1 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 27, 2020 Filed Aug 31, 2020 23:10 UTC |
Alinaya Rosabel RealicaVP, IR & Treasury
|
GrantRestricted Stock Unit | 71,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048850 · doc4.xml · nonDerivative · entry 2 Alinaya Rosabel Realica · CIK 0001665811 · VP, IR & Treasury 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,119 F3 · shares: The restricted stock unit will vest on May 22, 2023 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on August 27, 2020. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from August 27, 2020 until May 22, 2023 related to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:10 UTC |
Alinaya Rosabel RealicaVP, IR & Treasury
|
GrantRestricted Stock Unit | 59,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048850 · doc4.xml · nonDerivative · entry 1 Alinaya Rosabel Realica · CIK 0001665811 · VP, IR & Treasury 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,119 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:09 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
GrantRestricted Stock Unit | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048849 · doc4.xml · nonDerivative · entry 2 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,079 F3 · shares: The restricted stock unit will vest on May 22, 2023 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on August 27, 2020. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from August 27, 2020 until May 22, 2023 related to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:09 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
GrantRestricted Stock Unit | 164,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048849 · doc4.xml · nonDerivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,079 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:08 UTC |
Kocinsky JosephChief Technology Officer
|
GrantRestricted Stock Unit | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048848 · doc4.xml · nonDerivative · entry 2 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,517 F3 · shares: The restricted stock unit will vest on May 22, 2023 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on August 27, 2020. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from August 27, 2020 until May 22, 2023 related to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:08 UTC |
Kocinsky JosephChief Technology Officer
|
GrantRestricted Stock Unit | 164,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048848 · doc4.xml · nonDerivative · entry 1 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,517 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:07 UTC |
Galindo AlejandroChief Commercial Officer
|
GrantRestricted Stock Unit | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048847 · doc4.xml · nonDerivative · entry 2 Galindo Alejandro · CIK 0001821447 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,000 F3 · shares: The restricted stock unit will vest on May 22, 2023 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on August 27, 2020. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from August 27, 2020 until May 22, 2023 related to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:07 UTC |
Galindo AlejandroChief Commercial Officer
|
GrantRestricted Stock Unit | 164,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048847 · doc4.xml · nonDerivative · entry 1 Galindo Alejandro · CIK 0001821447 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,000 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:06 UTC |
Tross Stuart AChief People & Workpl Officer
|
GrantRestricted Stock Unit | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048846 · doc4.xml · nonDerivative · entry 2 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 478,720 F3 · shares: The restricted stock unit will vest on May 22, 2023 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on August 27, 2020. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from August 27, 2020 until May 22, 2023 related to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:06 UTC |
Tross Stuart AChief People & Workpl Officer
|
GrantRestricted Stock Unit | 164,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048846 · doc4.xml · nonDerivative · entry 1 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,720 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:06 UTC |
Binder Steven B.Chief Financial Officer
|
GrantRestricted Stock Unit | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048845 · doc4.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,265 F3 · shares: The restricted stock unit will vest on May 22, 2023 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on August 27, 2020. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from August 27, 2020 until May 22, 2023 related to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:06 UTC |
Binder Steven B.Chief Financial Officer
|
GrantRestricted Stock Unit | 164,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048845 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,265 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:05 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
GrantRestricted Stock Unit | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048844 · doc4.xml · nonDerivative · entry 2 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,112,560 F3 · shares: The restricted stock unit will vest on May 22, 2023 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on August 27, 2020. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from August 27, 2020 until May 22, 2023 related to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:05 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
GrantRestricted Stock Unit | 409,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048844 · doc4.xml · nonDerivative · entry 1 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 612,560 F1 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 22:45 UTC |
Binder Steven B.Chief Financial Officer
|
PurchaseCommon Stock, $0.01 Par Value | 1,522 | $1.25 | $1,902.50 |
DisclosureSEC source: 0001209191-20-044840 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,265 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on July 31, 2020. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 22:41 UTC |
Tross Stuart AChief People & Workpl Officer
|
PurchaseCommon Stock, $0.01 Par Value | 5,000 | $1.25 | $6,250.00 |
DisclosureSEC source: 0001209191-20-044833 · doc4.xml · nonDerivative · entry 1 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,720 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on July 31, 2020 representing the maximum allowable under the Plan for this period. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 22:39 UTC |
Kendall David MChief Medical Officer
|
PurchaseCommon Stock, $0.01 Par Value | 4,041 | $1.25 | $5,051.25 |
DisclosureSEC source: 0001209191-20-044829 · doc4.xml · nonDerivative · entry 1 Kendall David M · CIK 0001732647 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,059 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on July 31, 2020. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 22:38 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
PurchaseCommon Stock, $0.01 Par Value | 5,000 | $1.25 | $6,250.00 |
DisclosureSEC source: 0001209191-20-044826 · doc4.xml · nonDerivative · entry 1 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,560 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on July 31, 2020 representing the maximum allowable under the Plan for this period. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:36 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
PurchaseCommon Stock,$.01 par value | 293 | $1.48 | $433.64 |
DisclosureSEC source: 0001209191-20-037027 · doc4.xml · nonDerivative · entry 5 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Child Disclosed balance after: 293 Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:36 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
PurchaseCommon Stock,$.01 par value | 70 | $1.49 | $104.30 |
DisclosureSEC source: 0001209191-20-037027 · doc4.xml · nonDerivative · entry 4 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Child Disclosed balance after: 70 Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:36 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
PurchaseCommon Stock,$.01 par value | 10,000 | $1.41 | $14,100.00 |
DisclosureSEC source: 0001209191-20-037027 · doc4.xml · nonDerivative · entry 2 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 10,000 Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 21:36 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
PurchaseCommon Stock,$.01 par value | 30,000 | $1.49 | $44,700.00 |
DisclosureSEC source: 0001209191-20-037027 · doc4.xml · nonDerivative · entry 1 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,560 Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:36 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
PurchaseCommon Stock,$.01 par value | 68 | $1.41 | $95.88 |
DisclosureSEC source: 0001209191-20-037027 · doc4.xml · nonDerivative · entry 3 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Child Disclosed balance after: 68 Read SEC document |
| May 21, 2020 Filed May 27, 2020 00:24 UTC |
Shannon James SamuelDirector
|
GrantRestricted Stock Unit · Derivative | 38,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032198 · doc4.xml · derivative · entry 2 Shannon James Samuel · CIK 0001485417 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,760 Underlying: Common Stock · 38,760 shares Expires 2030-05-21 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F3 · derivative.exercise_date: Annual Retainer: Award granted in lieu of annual cash retainer payment. Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 21, 2020 Filed May 27, 2020 00:24 UTC |
Shannon James SamuelDirector
|
GrantRestricted Stock Unit · Derivative | 88,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032198 · doc4.xml · derivative · entry 1 Shannon James Samuel · CIK 0001485417 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,235 Underlying: Common Stock · 88,235 shares Expires 2030-05-21 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: Annual Equity Award: Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 21, 2020 Filed May 27, 2020 00:24 UTC |
MUNDKUR CHRISTINEDirector
|
GrantRestricted Stock Unit · Derivative | 88,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032197 · doc4.xml · derivative · entry 1 MUNDKUR CHRISTINE · CIK 0001237264 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,235 Underlying: Common Stock · 88,235 shares Expires 2030-05-21 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: Annual Equity Award: Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 21, 2020 Filed May 27, 2020 00:19 UTC |
HOOPER ANTHONY CDirector
|
GrantRestricted Stock Unit · Derivative | 38,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032196 · doc4.xml · derivative · entry 2 HOOPER ANTHONY C · CIK 0001277244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,760 Underlying: Common Stock · 38,760 shares Expires 2030-05-21 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F3 · derivative.exercise_date: Annual Retainer: Award granted in lieu of annual cash retainer payment. Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 21, 2020 Filed May 27, 2020 00:19 UTC |
HOOPER ANTHONY CDirector
|
GrantRestricted Stock Unit · Derivative | 88,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032196 · doc4.xml · derivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,235 Underlying: Common Stock · 88,235 shares Expires 2030-05-21 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: Annual Equity Award: Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 21, 2020 Filed May 27, 2020 00:18 UTC |
Grancio JenniferDirector
|
GrantRestricted Stock Unit · Derivative | 88,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032195 · doc4.xml · derivative · entry 1 Grancio Jennifer · CIK 0001807888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,235 Underlying: Common Stock · 88,235 shares Expires 2030-05-21 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: Annual Equity Award: Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 21, 2020 Filed May 27, 2020 00:17 UTC |
Friedman Michael ADirector
|
GrantRestricted Stock Unit · Derivative | 88,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032194 · doc4.xml · derivative · entry 1 Friedman Michael A · CIK 0001298083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,235 Underlying: Common Stock · 88,235 shares Expires 2030-05-21 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: Annual Equity Award: Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 21, 2020 Filed May 27, 2020 00:16 UTC |
Consiglio Ronald JDirector
|
GrantRestricted Stock Unit · Derivative | 38,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032193 · doc4.xml · derivative · entry 2 CONSIGLIO RONALD J · CIK 0001232088 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,760 Underlying: Common Stock · 38,760 shares Expires 2030-05-21 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F3 · derivative.exercise_date: Annual Retainer: Award granted in lieu of annual cash retainer payment. Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 21, 2020 Filed May 27, 2020 00:16 UTC |
Consiglio Ronald JDirector
|
GrantRestricted Stock Unit · Derivative | 88,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032193 · doc4.xml · derivative · entry 1 CONSIGLIO RONALD J · CIK 0001232088 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,235 Underlying: Common Stock · 88,235 shares Expires 2030-05-21 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: Annual Equity Award: Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 21, 2020 Filed May 27, 2020 00:15 UTC |
KRESA KENTDirector
|
GrantRestricted Stock Unit · Derivative | 38,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032192 · doc4.xml · derivative · entry 2 KRESA KENT · CIK 0001197571 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,760 Underlying: Common Stock · 38,760 shares Expires 2030-05-21 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F3 · derivative.exercise_date: Annual Retainer: Award granted in lieu of annual cash retainer payment. Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| May 21, 2020 Filed May 27, 2020 00:15 UTC |
KRESA KENTDirector
|
GrantRestricted Stock Unit · Derivative | 88,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032192 · doc4.xml · derivative · entry 1 KRESA KENT · CIK 0001197571 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,235 Underlying: Common Stock · 88,235 shares Expires 2030-05-21 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · derivative.exercise_date: Annual Equity Award: Restricted stock unit shall vest immediately, but the shares shall not be delivered until there is a separation of service, such as through resignation or retirement from the Board or his or her death. Read SEC document |
| March 23, 2020 Filed Mar 26, 2020 23:08 UTC |
Grancio JenniferDirector
|
GrantRestricted Stock Unit | 12,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-021344 · doc4.xml · nonDerivative · entry 1 Grancio Jennifer · CIK 0001807888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,019 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Restricted stock unit shall vest immediately, but the shares shall not be delivered until the director leaves the Board. Read SEC document |
| March 04, 2020 Filed Mar 5, 2020 01:24 UTC |
HOOPER ANTHONY CDirector
|
GrantRestricted Stock Unit | 30,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-016410 · doc4.xml · nonDerivative · entry 1 HOOPER ANTHONY C · CIK 0001277244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,201 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Restricted stock unit shall vest immediately, but the shares shall not be delivered until the director leaves the Board. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC |
Tross Stuart AChief People & Workpl Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 20,000 | $2.70 Strike: $2.70 | $54,000.00 |
DisclosureSEC source: 0001209191-20-013626 · doc4.xml · derivative · entry 2 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Stock Options · 20,000 shares Expires 2027-02-16 F2 · kind: On February 16, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC |
Tross Stuart AChief People & Workpl Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 28,144 | $1.42 Strike: $1.42 | $39,964.48 |
DisclosureSEC source: 0001209191-20-013626 · doc4.xml · derivative · entry 1 Tross Stuart A · CIK 0001589641 · Chief People & Workpl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,144 Underlying: Stock Options · 28,144 shares Expires 2027-05-25 F1 · kind: On May 25, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC |
Binder Steven B.Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 45,025 | $1.47 Strike: $1.47 | $66,186.75 |
DisclosureSEC source: 0001209191-20-013629 · doc4.xml · derivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,025 Underlying: Stock Options · 45,025 shares Expires 2027-08-24 F1 · kind: On August 24, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC |
Kocinsky JosephChief Technology Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 37,525 | $1.42 Strike: $1.42 | $53,285.50 |
DisclosureSEC source: 0001209191-20-013628 · doc4.xml · derivative · entry 2 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,525 Underlying: Stock Options · 37,525 shares Expires 2027-05-25 F2 · kind: On May 25, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC |
Kocinsky JosephChief Technology Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 20,000 | $4.55 Strike: $4.55 | $91,000.00 |
DisclosureSEC source: 0001209191-20-013628 · doc4.xml · derivative · entry 1 Kocinsky Joseph · CIK 0001655595 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Stock Options · 20,000 shares Expires 2026-05-19 F1 · kind: On May 19, 2016, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 37,525 | $1.42 Strike: $1.42 | $53,285.50 |
DisclosureSEC source: 0001209191-20-013627 · doc4.xml · derivative · entry 2 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,525 Underlying: Stock Options · 37,525 shares Expires 2027-05-25 F2 · kind: On May 25, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC |
Thomson DavidEVP Genl Counsel & Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 20,000 | $4.55 Strike: $4.55 | $91,000.00 |
DisclosureSEC source: 0001209191-20-013627 · doc4.xml · derivative · entry 1 Thomson David · CIK 0001297976 · EVP Genl Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Stock Options · 20,000 shares Expires 2026-05-19 F1 · kind: On May 19, 2016, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC |
Alinaya Rosabel RealicaVP, IR & Treasury
|
GrantEmployee Stock Option (right to buy) · Derivative | 15,750 | $1.42 Strike: $1.42 | $22,365.00 |
DisclosureSEC source: 0001209191-20-013624 · doc4.xml · derivative · entry 3 Alinaya Rosabel Realica · CIK 0001665811 · VP, IR & Treasury 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Underlying: Stock Options · 15,750 shares Expires 2027-05-25 F3 · kind: On May 25, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC |
Alinaya Rosabel RealicaVP, IR & Treasury
|
GrantEmployee Stock Option (right to buy) · Derivative | 12,500 | $1.52 Strike: $1.52 | $19,000.00 |
DisclosureSEC source: 0001209191-20-013624 · doc4.xml · derivative · entry 2 Alinaya Rosabel Realica · CIK 0001665811 · VP, IR & Treasury 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Stock Options · 12,500 shares Expires 2027-05-29 F2 · kind: On May 29, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC |
Alinaya Rosabel RealicaVP, IR & Treasury
|
GrantEmployee Stock Option (right to buy) · Derivative | 20,000 | $4.55 Strike: $4.55 | $91,000.00 |
DisclosureSEC source: 0001209191-20-013624 · doc4.xml · derivative · entry 1 Alinaya Rosabel Realica · CIK 0001665811 · VP, IR & Treasury 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Stock Options · 20,000 shares Expires 2026-05-19 F1 · kind: On May 19, 2016, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 37,525 | $1.42 Strike: $1.42 | $53,285.50 |
DisclosureSEC source: 0001209191-20-013625 · doc4.xml · derivative · entry 3 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,525 Underlying: Stock Options · 37,525 shares Expires 2027-05-25 F3 · kind: On May 25, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 57,750 | $1.52 Strike: $1.52 | $87,780.00 |
DisclosureSEC source: 0001209191-20-013625 · doc4.xml · derivative · entry 2 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,750 Underlying: Stock Options · 57,750 shares Expires 2027-05-29 F2 · kind: On May 29, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC |
Castagna MichaelDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 50,000 | $4.55 Strike: $4.55 | $227,500.00 |
DisclosureSEC source: 0001209191-20-013625 · doc4.xml · derivative · entry 1 Castagna Michael · CIK 0001674282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Stock Options · 50,000 shares Expires 2026-05-19 F1 · kind: On May 19, 2016, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC |
McCauley PatrickChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 45,025 | $1.47 Strike: $1.47 | $66,186.75 |
DisclosureSEC source: 0001209191-20-013623 · doc4.xml · derivative · entry 1 McCauley Patrick · CIK 0001712607 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,025 Underlying: Stock Options · 45,025 shares Expires 2027-08-24 F1 · kind: On August 24, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.